Infant Vaccinations among Mothers with Substance-Use Disorders: A Comparative Study.

Autor: Falkenberg-Olson AC; Gundersen Health System-Gundersen Medical Foundation, La Crosse, WI., Hayter KL; Gundersen Health System-Gundersen Medical Foundation, La Crosse, WI klhayter@gundersenhealth.org., Holzer RA; Gundersen Health System, La Crosse, WI., Laylan JM; Gundersen Health System, La Crosse, WI., Borgert AJ; Gundersen Health System-Gundersen Medical Foundation, La Crosse, WI., Budzak Garza AE; Gundersen Health System, La Crosse, WI.
Jazyk: angličtina
Zdroj: Clinical medicine & research [Clin Med Res] 2021 Mar; Vol. 19 (1), pp. 3-9. Date of Electronic Publication: 2020 Oct 14.
DOI: 10.3121/cmr.2020.1580
Abstrakt: Introduction: Infants of mothers with substance use disorder (SUD) are exposed to complex social environments and increased childhood health risks that can lead to adverse consequences throughout the lifespan. GunderKids, a voluntary, specialized, comprehensive pediatric care management program, was developed to mitigate many of these adverse consequences. Our organization is evaluating several clinical outcomes related to health and development in children born to women with SUD. The current study addressed the timeliness of vaccination coverage among these infants. Methods: This descriptive comparative preliminary study evaluated data of infants and their mothers with SUD who were previously identified during prenatal care visits either by self-report or by positive urine screens. Sociodemographic and vaccination data were extracted from a longitudinal master dataset of variables developed and maintained through retrospective review of electronic health records (EHRs) of these mothers and their infants. Timeliness of vaccination coverage of SUD-exposed infants participating in GunderKids was compared with that of SUD-exposed infants receiving standard pediatric care and was determined using a cumulative vaccinations method. Results: Overall, infants in the GunderKids group (n=50) had more timely vaccination coverage than those receiving standard pediatric care (n=20). Examples of timelier coverage included Haemophilus influenzae type b (Hib) at 4 months ( P = .01; OR 4.3, 95% CI 1.4-13.4), for pneumococcal ( P = .004; OR 6.6, 95% CI 1.8-23.8) and Hib ( P = .004; OR 5.8, 95% CI 1.6-21.9) vaccinations at 15 months. More than 77% of GunderKids received all 6-month vaccinations in a timely manner compared with less than 45% of the standard care group; odds ratios suggest that GunderKids had 4.0-5.6 higher odds of receiving 6-month vaccinations. Conclusion: Vaccination coverage of infants participating in GunderKids was timelier than that of infants receiving standard pediatric care. Results suggest that specialized programs like GunderKids may assist in mitigating adverse health consequences and timeliness of vaccination coverage might be used as a proxy for measuring program effectiveness. Further investigation is recommended to determine clinical, individual, and organizational factors that influence parental behaviors and pediatric outcomes within SUD-exposed families.
(Copyright © 2021 Marshfield Clinic Health System.)
Databáze: MEDLINE
Externí odkaz: